Epidemiology in dermatology and evaluation of therapeutics

Recent papers from Epidemiology in dermatology and evaluation of therapeutics

1. Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trialsNature Medicine · 2026
2. Local treatments of psoriasis and atopic dermatitis: From pharmacological targets to meta-analysesTherapies · 2026
3. Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndromeBritish Journal of Dermatology · 2026
4. Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized TrialsRheumatology and Therapy · 2025
5. MALTectomy and psoriasis risk in women: A prospective study in the French E3N prospective cohortPLoS ONE · 2024
6. Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesJournal of the American Society of Nephrology · 2024
7. Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in AdultsJAMA Dermatology · 2024
8. Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort studyJournal of the European Academy of Dermatology and Venereology · 2024
9. Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analysesAnnals of Internal Medicine · 2024
10. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort studyThe Lancet Regional Health - Europe · 2024
11. Use of progestogens and the risk of intracranial meningioma: national case-control studyBMJ · 2024
12. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult PatientsJAMA Dermatology · 2024
13. Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data SystemRMD Open · 2024
14. Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS)RMD Open · 2024
15. Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney TransplantationTransplant International · 2024
16. Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patientsBritish Journal of Dermatology · 2023
17. Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoJournal of Allergy and Clinical Immunology · 2023
18. A prospective study of the association between living in a rural environment during childhood and risk of psoriasisEnvironmental Research · 2023
19. Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic reviewJournal of the European Academy of Dermatology and Venereology · 2023
20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysisCochrane library · 2023